RNS Number : 0895W
Ultra Electronics Holdings PLC
06 December 2019
Ultra Electronics Holdings plc (the "Company")
PDMR Transaction notification
The Company has been notified that on 5 December 2019, Daniel Shook, Non-Executive Director, purchased 2,500 ordinary shares of 5p each in the Company ("Ordinary Shares") at £20.095 per ordinary share.
Following the purchase, Mr. Shook has a beneficial interest in 2,500 Ordinary Shares, representing approximately 0.004% of the Company's issued share capital.
The following notification is made in accordance with Article 19 of the Market Abuse Regulation and Rule 3.1 of the Disclosure and Transparency Rules.
Enquiries:
Cherise Trumper +44 (0) 0208 813 4321
For and on behalf of Ultra Electronics Holdings plc
Louise Ruppel
General Counsel & Company Secretary
|
1.
|
Details of PDMR / person closely associated with them ("PCA")
|
|
a)
|
Name
|
Daniel Shook
|
|
b)
|
Position / status
|
Non-Executive Director/PDMR
|
|
c)
|
Initial notification / amendment
|
Initial notification
|
|
2
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Ultra Electronics Holdings plc
|
|
b)
|
LEI
|
213800E68EATZGAJIP64
|
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a)
|
Description of the financial instrument
Identification Code
|
5p Ordinary Shares
GB0009123323
|
|
b)
|
Nature of the transaction
|
Purchase
|
|
c)
|
Price(s) and volume(s)
|
|
Price
|
Volume(s)
|
|
£20.095
|
2,500
|
|
|
d)
|
Aggregated information
Aggregated volume
Price
|
2,500
£50,237.50
|
|
e)
|
Date of the transaction
|
5 December 2019
|
|
f)
|
Place of the transaction
|
London Stock Exchange
|
|
|
|
|
|
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com or visit
www.rns.com.
END
DSHFSEFDMFUSEDE